Clinical Trials Browser

Carcinoma, Ovarian Epithelial, Adenocarcinoma, Bile Duct Neoplasms, Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Carcinoma, Small Cell, Carcinoma, Ductal, Small Cell Lung Carcinoma, Inflammatory Breast Neoplasms

Clinical Trials

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

ASCEND

A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors

Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors

GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results

Surufatinib Combined With KN046 and AG Regimen Chemotherapy as First-Line Treatment for Unresectable Advanced Pancreatic Cancer

A Study of HY-0102 in Patients With Advanced Solid Tumors

U87 CART in Treatment of Advanced Solid Tumor

Nimotuzumab Plus AG in Pancreatic Cancer With Liver Metastasis

MIRCA & MIPAC

PRIORITY-CONNECT 2 Pilot Trial

A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Neoadjuvant CCRT With Gemcitabine/Durvalumab (MEDI4736) Followed by Adjuvant Gemcitabine/Durvalumab(MEDI4736) in Resectable or Borderline Resectable Pancreatic Cancer

NaliCap

Pembrolizumab Plus Chemotherapy in 1st Line Treatment of Pancreatic Cancer

C3

A Study of the Treatment of Disitamab Vedotin in Patients With Locally Advanced or Metastatic Pancreatic Cancer

Intraoperative Radiation Therapy for Resectable Pancreatic Cancer

REMBRANDT

EUS-CTC

Prophylactic Administration of Neulapeg (Pegteograstim) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Receiving the Modified FOLFIRINOX

MIKE-1

PANORAMA

A Study of GB201 in Combination With Weekly Paclitaxel and Low-dose Gemcitabine in Patients With Pancreatic Cancer

A Prospective, Randomized, Double-blinded, Multi-center Clinical Trial to Evaluate the Efficiency and Safety of Anti-PD1 Antibody (Camrelizumab) Combined With Paclitaxel(Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer

Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

IMAGene

Peri-operative SLOG for Localized Pancreatic Cancer

Combined Exercise and Nutritional Intervention in GI Cancer Patients

MK-3475-E90

Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression

The Application of Probe Confocal Laser Endomicroscopy in Pancreatic Tumor Surgery

DCE-MRI

Nab-PIPAC

Graphic Novel for Patients Undergoing EUS-FNB

Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation (IRE) System

VUBAR

Clinical Study of CLDN18.2 PET/CT for Noninvasive Diagnosis of Gastric and Pancreatic Cancer

PRIMUS 001: A Study Looking at Two Different Chemotherapy Regimens in Patients With Metastatic Pancreatic Cancer

Precision-Panc Master Protocol: Personalising Treatment for Pancreatic Cancer

Cancer

Phase II Study of Concurrent Radiotherapy With Envafolimab and Capecitabine in LAPC

HOLIPANC

Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors

Contrast Enhanced Endoscopic Ultrasound in Pancreas Lesions

DICI_PC

GENDER

Cadonilimab Plus mFOLFIRINOX as Conversion Therapy in LAPC

Carbon Ion Radiotherapy for Locally Advanced Pancreatic Cancer

Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer